Page 27

crf_rapport_rgb_singlepage

Furthermore, healthcare professionals should be well equipped INNOVATION IMPACT to communicate about biomedical research and funding agen- Healthcare is a driving factor for different industries in most cies should require researchers to report their plans for involving European countries, which means investments in research and patients and the public in their research projects. This also involves innovation will pay off for Europe as new concepts in therapy a system of scientifi c publications and information retrieval in can be exported worldwide. Biomedical research is necessary which free access to all (published) information is guaranteed. for providing jobs and growth in the European pharmaceutical Open access could be provided through institutional repositories industry, in biotech, and in the medical technology device industry. by the authors or by directly publishing in open access journals However, innovation in Europe faces important structural impedi- with publishing costs paid by the authors’ institutions, grants, or ments. Europe’s system of capital provision is not well adapted philanthropic support. to high-tech research, both in terms of its appetite for speculative investment and its ability to operate across borders. Attempts to fi ll Another important issue is the creation and maintenance of an this gap with centralised funding programs, such as the IMI, while open trial registry for trial protocols and results which can in turn highly welcomed, can only go so far. be linked to approval by relevant ethics committees, while also working towards allowing conditional public access to full clinical To facilitate this coordination of European health research activi- trial data sets. Furthermore, investigator-led clinical trials have the ties, funding should include the entire chain of innovation, from potential to contribute widely to the body of research but need to basic research to the technical and organisational implementation be easier to undertake, much more widespread, and less burdened of a new innovation. Programmes such as EUROHORCs’ Money by bureaucracy such as introduced by the European Clinical Trials Follows Researcher scheme, the development of Money Follows Co- Directive, 2001. operation schemes, as well as further work on common administra- tive procedures would also greatly improve coordination. The proposal for Horizon 2020 will simplify the rules for participa- tion including abolition of time sheets for staff that work full-time. At present there is no European platform between stakeholders This is an important issue; however it should be extended to part- that covers a variety of fi elds, from bench to bedside, from clinic to time workers. In health research a high proportion of researchers community, and no common overview on health and biomedicine work part time, as they are physicians and researchers at the same research implementation in clinical practice and health-related time. The bureaucratic burden of the time sheets makes this funding industry. Establishing a “European Strategic Action for Healthier less attractive, and “best practice” for NIH, MRC, and Wellcome Europeans” designed to aid strategic long-term planning driven Trust should be consulted. by healthcare and optimising healthcare delivery across Europe through high level treatment guidelines and a shared understand- Regulators and directives etc. at both EU and national levels must ing of how health technology assessments can deliver value for keep up with the rapidly developing technological advances in money will be an important instrument. An additional goal will be medicine to facilitate research and optimize patients access to new establishing a virtual infrastructure that can provide “a one-stop treatments. Moreover, the regulatory issues and the directive of shop” where front-line research groups and laboratories can fi nd clinical and other types of research need to facilitate researcher information and people with the expertise they need. and not the opposite. 28


crf_rapport_rgb_singlepage
To see the actual publication please follow the link above